Atlas Trials

LucasBio

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch LucasBio

RecordFirmDate
Evaluation of the Safety and Efficacy of LB-DTK-BKV in Patients With BK Virus-Associated Hemorrhagic Cystitis Following Allogeneic Hematopoietic Stem Cell Transplantation (NCT07638332)LucasBio2026-09-01
Evaluation of Safety and Efficacy of Autologous LB-DTK-CMV in Patients With Antiviral-Resistant and Refractory Cytomegalovirus Retinitis. (NCT07679412)LucasBio2026-04-27
Evaluation of Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infection Following Allogeneic Hematopoietic Stem Cell Transplantation. (NCT07685457)LucasBio2026-02-10
Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation. (NCT07670468)LucasBio2025-12-04
Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 Patients (NCT07709637)LucasBio2025-07-31
Evaluation of the Safety and Efficacy of Autologous COVID-19 Antigen Specific T Cell in Prolonged SARS-CoV-2 Patients (NCT07690943)LucasBio2023-06-08
Evaluation of the Safety of Cytokine-Induced-Killer Cells During Early Transplant Period of Autologous Hematopoietic Stem Cell Transplant Recipients. (NCT07692607)LucasBio2022-03-28

Track LucasBio automatically

Every clearance here is in the API, with alerts when new ones post.